SCHEMBL18924667

SCHEMBL18924667

C[C@@H](N)C(=O)OCOn1nnc2ccc(C(=O)N[C@H](Cc3ccc(-c4cccc(Cl)c4)cc3)C[C@@H](O)C(=O)O)cc21

nearest known ligand 0.82

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ACE P12821 9/20 0.82
EMG1 Q92979 2/20 0.82
MME P08473 18/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20489347 0.94 ACE (0.80) ACEEMG1MME
SCHEMBL17011166 0.94 ACE (0.80) ACEEMG1MME
SCHEMBL19708665 0.94 ACE (0.80) ACEEMG1MME
SCHEMBL19190283 0.92 ACE (0.85) ACEEMG1MME
SCHEMBL17011160 0.92 ACE (0.85) ACEEMG1MME
SCHEMBL19708667 0.92 ACE (0.84) ACEEMG1MME
SCHEMBL17011165 0.90 ACE (1.00) ACEEMG1MME
SCHEMBL19825615 0.90 ACE (0.77) ACEEMG1MME
SCHEMBL17011167 0.90 ACE (0.77) ACEEMG1MME
SCHEMBL19825614 0.90 ACE (0.77) ACEEMG1MME

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9670140-B2 Neprilysin inhibitors THERAVANCE BIOPHARMA R&D IP, LLC (US) 2017-06-06 US disclosed